Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Northwestern University Identifier:
First received: March 7, 2000
Last updated: May 31, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2000
  Primary Completion Date: February 2000 (Final data collection date for primary outcome measure)